Global Retirement Partners’s Theravance Biopharma TBPH Stock Holding History

Global Retirement Partners’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$5.61K	Hold	300	–	–	﹤0.01%	3399
2025 Q3	$4.38K	Hold	300	–	–	﹤0.01%	3029
2025 Q2	$3.31K	Buy	+300	New	+$2.92K	﹤0.01%	3056
2024 Q4	$2.82K	Hold	300	–	–	﹤0.01%	2940
2024 Q3	$2.42K	Hold	300	–	–	﹤0.01%	2878
2024 Q2	$2.54K	Hold	300	–	–	﹤0.01%	2884
2024 Q1	$2.69K	Hold	300	–	–	﹤0.01%	2633
2023 Q4	$2.89K	Hold	300	–	–	﹤0.01%	2533
2023 Q3	$2.64K	Hold	300	–	–	﹤0.01%	2427
2023 Q2	$3.1K	Hold	300	–	–	﹤0.01%	2382
2023 Q1	$3.37K	Hold	300	–	–	﹤0.01%	2305
2022 Q4	$3.37K	Buy	+300	New	+$3.15K	﹤0.01%	2160
2020 Q1	–	Sell	-57	Closed	-$1K	–	1683
2019 Q4	$1K	Hold	57	–	–	﹤0.01%	1568
2019 Q3	$1K	Hold	57	–	–	﹤0.01%	1552
2019 Q2	$1K	Buy	+57	New	+$1.16K	﹤0.01%	1547

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICM

Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Global Retirement Partners's TBPH Position: Q4 2025 in Review

Global Retirement Partners held its Theravance Biopharma (TBPH) position steady in Q4 2025 at 300 shares worth $5.61K. The position accounts for ﹤0.01% of the portfolio, ranked #3399.

Global Retirement Partners first reported a position in TBPH in Q2 2019 and has held it in 15 quarters since. 169 funds tracked by Wall St. Rank hold TBPH as of Q4 2025.

Global Retirement Partners held 300 shares of Theravance Biopharma worth $5.61K as of Q4 2025.
Global Retirement Partners left its Theravance Biopharma share count unchanged in Q4 2025.
Theravance Biopharma made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3399 holding.
Global Retirement Partners first reported a position in Theravance Biopharma in Q2 2019 and has held it in 15 quarters since.
169 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.